GlassScriptPhysician profile
Lawrence D Boysen
NPI 1639170335
$736.73
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $284 · 2020: $20.01 · 2021: $102 · 2022: $330.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $159.38 | 2019-2022 | |
| Organon LLC | $88.15 | 2022 | |
| Abbvie INC. | $82.68 | 2019 | |
| Aspira Women'S Health INC | $80.64 | 2021-2022 | |
| Lupin INC. | $75.00 | 2019-2020 | |
| Therapeuticsmd, INC. | $58.59 | 2019-2022 | |
| Astellas Pharma US INC | $33.62 | 2019-2022 | |
| Duchesnay USA Incorporated | $27.23 | 2019 | |
| Allergan, INC. | $24.69 | 2019 | |
| Becton, Dickinson and Company | $23.36 | 2021 | |
| Agile Therapeutics, INC. | $18.90 | 2021 | |
| Amag Pharmaceuticals, INC. | $17.87 | 2019 | |
| Boston Scientific Corporation | $16.20 | 2019 | |
| Mayne Pharma Commercial LLC | $15.26 | 2022 | |
| Avion Pharmaceuticals | $15.16 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lawrence Boysen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.